Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0606920170250060641
Biomolecules & Therapeutics
2017 Volume.25 No. 6 p.641 ~ p.647
Galangin Suppresses Pro-Inflammatory Gene Expression in Polyinosinic-Polycytidylic Acid-Stimulated Microglial Cells
Choi Min-Ji

Park Jin-Sun
Park Jung-Eun
Kim Han-Su
Kim Hee-Sun
Abstract
Galangin (3,5,7-trihydroxyflavone) is a polyphenolic compound abundant in honey and medicinal herbs, such as Alpinia officinarum. In this study, we investigated the anti-inflammatory effects of galangin under in vitro and in vivo neuroinflammatory conditions caused by polyinosinic-polycytidylic acid (poly(I:C)), a viral mimic dsRNA analog. Galangin suppressed the production of nitric oxide, reactive oxygen species, and pro-inflammatory cytokines in poly(I:C)-stimulated BV2 microglia. On the other hand, galangin enhanced anti-inflammatory interleukin (IL)-10 production. Galangin also suppressed the expression of pro-inflammatory markers in poly(I:C)-injected mouse brains. Further mechanistic studies showed that galangin inhibited poly(I:C)-induced nuclear factor (NF)-¥êB activity and phosphorylation of Akt without affecting MAP kinases. Interestingly, galangin increased the expression and transcriptional activity of peroxisome proliferator-activated receptor (PPAR)-¥ã, known to play an anti-inflammatory role. To investigate whether PPAR-¥ã is involved in the anti-inflammatory function of galangin, BV2 cells were pre-treated with PPAR-¥ã antagonist before treatment of galangin. We found that PPAR-¥ã antagonist significantly blocked galangin-mediated upregulation of IL-10 and attenuated the inhibition of tumor necrosis factor (TNF)-¥á and IL-6 in poly(I:C)-stimulated microglia. In conclusion, our data suggest that PI3K/Akt, NF-¥êB, and PPAR-¥ã play a pivotal role in mediating the anti-inflammatory effects of galangin in poly(I:C)-stimulated microglia.
KEYWORD
Galangin, Poly(I:C), Microglia, PI3K/Akt, NF-¥êB, PPAR-¥ã signaling
FullTexts / Linksout information
Listed journal information
SCI(E) ÇмúÁøÈïÀç´Ü(KCI) KoreaMed